ACSS2 Regulates HIF-2α Degradation through the E3-Ubiquitin Ligase MUL1 in Clear Cell Renal Cell Carcinoma
Bacigalupa, Z. A.; Brown, W. A.; Krystofiak, E. S.; Wolf, M. M.; Hongo, R. A.; Landis, M.; Amason, E. K.; Beckermann, K. E.; Rathmell, J.; Rathmell, W. K.
Show abstract
Clear cell renal cell carcinoma (ccRCC) is an aggressive kidney cancer driven by VHL loss and aberrant HIF-2 signaling. Acetate metabolism may contribute to this axis by ACSS2-dependent acetylation of HIF-2 and may provide opportunities to intervention. Here we tested the effects of pharmacological and genetic manipulation of ACSS2 on HIF-2, ccRCC cells, and tumors. ACSS2 inhibition led to HIF-2 degradation and suppressed ccRCC growth in vitro, in vivo, and in primary cell cultures of ccRCC patient tumors. This treatment resulted in reduced glucose and cholesterol metabolism, mitochondrial biogenesis and altered cristae deformation, that are consistent with loss of HIF-2. Mechanistically, HIF-2 protein levels are regulated through proteolytic degradation and we found, in parallel to VHL, HIF-2 stability was dependent on ACSS2 activity to prevent direct interaction with the E3 ligase MUL1. These findings highlight ACSS2 as a critical upstream regulator of HIF-2 that may be exploited to overcome resistance to HIF-2 inhibitor therapies. STATEMENT OF SIGNIFICANCEWe have unveiled ACSS2 as a critical upstream regulator of HIF-2 in ccRCC. Targeting ACSS2 potently promotes HIF-2 degradation via MUL1 to effectively deplete mitochondrial activity and block ccRCC primary tumor models and growth models resistant to HIF-2 inhibitor therapy.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Lysosomal mitochondrial interaction promotes tumor growth in squamous cell carcinoma of the head and neck 95%
- The target gene regulatory network of miR-497 in angiosarcoma 95%
- Mediator of DNA damage checkpoint 1 (MDC1) is a novel estrogen receptor co-regulator in invasive lobular carcinoma of the breast 94%
Similar papers in this journal
- HIF-dependent expression of creatine kinase brain isoform (CKB) promotes breast cancer metastasis, whereas cyclocreatine therapy impairs invasion and improves the efficacy of conventional chemotherapies 96%
- The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma 95%
- Histone deacetylase inhibitor induces acetyl-CoA depletion leading to lethal metabolic stress in RAS-pathway activated cells 95%
Similar papers in this journal
- The Cancer Testis Antigen Testis Specific Serine Kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors 95%
- VHL inhibitor binding increases intracellular level of VHL 95%
- The Hippo pathway effector YAP inhibits NF-kB signaling and ccRCC growth by opposing ZHX2 95%
Similar papers in this journal
Similar papers in this journal
- Integrative analysis of patient-derived tumoroids and ex vivo organoid modeling of ARID1A loss in bladder cancer reveals therapeutic molecular targets 95%
- UDP-Glucose 6-Dehydrogenase Knockout Impairs Migration and Decreases in vivo Metastatic Ability of Breast Cancer Cells 95%
- REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM kinase activity 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.